Covered recipient · General Payments record
BARBARA G C HOOVER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,147.21
- Reported across 85 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $415.48 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $93.66 | 4 |
| PFIZER INC. | $89.94 | 4 |
| Lilly USA, LLC | $89.29 | 2 |
| Abbott Laboratories | $45.35 | 2 |
| Exact Sciences Corporation | $40.08 | 2 |
| Amgen Inc. | $26.64 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.62 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $13.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.66 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125251286 | CMS |
| Abbott Laboratories | $23.69 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125251290 | CMS |
| Amgen Inc. | $26.64 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111601280 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $13.90 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086173862 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.62 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118142774 | CMS |
| Exact Sciences Corporation | $19.32 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114707267 | CMS |
| Exact Sciences Corporation | $20.76 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114707274 | CMS |
| Lilly USA, LLC | $21.61 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136073211 | CMS |
| Lilly USA, LLC | $67.68 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136073213 | CMS |
| Novo Nordisk Inc | $23.98 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097164261 | CMS |
| Novo Nordisk Inc | $21.57 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097227002 | CMS |
| Novo Nordisk Inc | $23.44 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096819235 | CMS |
| Novo Nordisk Inc | $24.67 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097588155 | CMS |
| PFIZER INC. | $22.42 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132028323 | CMS |
| PFIZER INC. | $18.85 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132035114 | CMS |
| PFIZER INC. | $26.40 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131095268 | CMS |
| PFIZER INC. | $22.27 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131221423 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.